The Latest Cardiac and Vascular News
ABBOTT PARK, Ill. and EDEN PRAIRIE, Minn., Feb. 27, 2018 /PRNewswire/ — Abbott (NYSE: ABT) and Surmodics (NASDAQ: SRDX) today announced that the companies have entered into an agreement whereby Abbott will have exclusive worldwide commercialization rights for Surmodics’ SurVeil® drug-coated balloon to treat the superficial femoral artery, which is currently being evaluated in a U.S. pivotal […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott is stepping down as the Company’s Chief Executive Officer. To facilitate a smooth transition, Mr. McDermott has committed to remaining in his current role until a successor is found. Daniel T. […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (Formerly known as Corindus), Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today the successful completion of the first robotic-assisted peripheral vascular intervention procedure using the recently FDA-cleared CorPath GRX System. The procedure was performed by Joseph Ricotta, M.D., Medical Director […]
SUNNYVALE, Calif.–(BUSINESS WIRE)– PQ Bypass, a clinical-stage medical technology company that has developed the DETOUR procedure, a novel treatment for long (>15 cm) superficial femoral artery (SFA) blockages, announced enrollment of the first patients in the pivotal DETOUR II Trial in the United States. The trial is a prospective, single-arm clinical […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its CorPath GRX System in peripheral vascular interventions. The CorPath System is the first and only FDA-cleared […]
BLOOMINGTON, Ind.–(BUSINESS WIRE)– Today, Cook Medical announced key changes that simplify its organizational structure to better support customers. These changes realign the current sales, marketing, research and development, and customer service teams in addition to establishing new distribution channel management and medical education teams. The changes are a direct result of feedback […]
Feb. 14, 2018 12:00 UTC Device provides alternative access point to treat patients suffering from peripheral artery disease ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today that the first patients were […]
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) — Endonovo Therapeutics (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced positive results from a study of critical limb ischemia (CLI) in mice. Animals treated three times per day with the Company’s Pulsed Electromagnetic Fields (PEMF) […]
Audio Recording: Learn more about Silk Road’s TCAR technology with and Interview from their Chief Medical Officer, Dr. Sumaira Macdonald at an interview that took place at a busy Denver International Airport as she speaks with CardiacVascularNews.
Feb. 7, 2018 14:30 UTC WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular interventions announces positive results from the First-in-Human PRELUDE Study. Dr. Andrew Holden (Auckland, New Zealand), Principal Investigator, presented 30-day and preliminary 6-month results using the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon […]
